Clinical trial
Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor…
NCT00143780 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00143780 |
|---|---|
| Title | Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination |
| Official title | Immunogenicity of Pneumococcal Conjugate Vaccine in Adult Allogeneic Bone Marrow Transplant Recipients - Randomized Controlled Trial of Pre-Transplant Donor Immunization |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | The Physicians' Services Incorporated Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bone Marrow Transplant |
| Intervention type | Biological |
| Interventions | The polysaccharide vaccine used is Pneumovax (Merck vaccines), The conjugate vaccine used is Prevnar (Wyeth-Ayerst vaccines) |
| Enrollment | 70 |
| Start date | May 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Apr 16, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: